Prospective individual patient data meta-analysis: evaluating convalescent plasma for COVID-19

DOI10.1002/SIM.9115MaRDI QIDQ6628017zbMATH OpenFDO

Authors Keith S. Goldfeld, Danni Wu, Thaddeus Tarpey, Mengling Liu, Yinxiang Wu, Andrea B. Troxel, Eva Petkova

Publication date 29 October 2024

Published in Statistics in Medicine (Search for Journal in Brave)

Copyright license Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Full work available at URL https://doi.org/10.1002/SIM.9115

zbMATH Keywords

Bayesian data and safety monitoringinternational consortium for data sharing from ongoing RCTsstatistical analysis planstopping rules

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• A class of k-sample tests for comparing the cumulative incidence of a competing risk
• A constrained single‐index regression for estimating interactions between a treatment and covariates
• A Proportional Hazards Model for the Subdistribution of a Competing Risk
• Checking the Cox model with cumulative sums of martingale-based residuals
• Constructing treatment decision rules based on scalar and functional predictors when moderators of treatment effect are unknown
• Estimating individualized treatment rules using outcome weighted learning
• Optimal Dynamic Treatment Regimes
• Performance guarantees for individualized treatment rules

Cited in

(1)

• A Bayesian multi-factorial design and analysis for estimating combined effects of multiple interventions in a pragmatic clinical trial to improve dementia care

This page was built for publication: Prospective individual patient data meta-analysis: evaluating convalescent plasma for COVID-19

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628017)